Clinical appraisal of handheld intestinal ultrasound in inflammatory bowel disease: Where are we now?

IF 5.5 3区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY
Yusuke Miyatani, Alexandra Hudson, Amelia Kellar, Joëlle St-Pierre, On Behalf Of The Intestinal Ultrasound Group Of The United States And Canada iUSCAN Research Committee
{"title":"Clinical appraisal of handheld intestinal ultrasound in inflammatory bowel disease: Where are we now?","authors":"Yusuke Miyatani, Alexandra Hudson, Amelia Kellar, Joëlle St-Pierre, On Behalf Of The Intestinal Ultrasound Group Of The United States And Canada iUSCAN Research Committee","doi":"10.1093/ibd/izag147","DOIUrl":null,"url":null,"abstract":"<p><p>Gastroenterologist-performed intestinal ultrasound (IUS) is increasingly used to monitor inflammatory bowel disease (IBD) due to its noninvasive, real-time, and cost-effective attributes, alongside high diagnostic accuracy. However, wider adoption remains limited by the cost, size, and workflow demands of cart-based or high-end ultrasound platforms. Handheld ultrasound has emerged as a miniaturized alternative that can be and applied at the bedside. Early studies of handheld intestinal ultrasound (HHIUS) in IBD have demonstrated reproducibility and diagnostic performance comparable to conventional IUS for selected applications, particularly bowel wall thickness assessment, with limitations in assessing deep pelvic lesion and complications. Whereas interdevice comparisons specific to IBD are lacking, data from general medicine suggest rapid improvements in image quality and usability of handheld devices. However, most comparative studies have not evaluated color Doppler, a core IUS parameter. In ulcerative colitis, Doppler-inclusive assessment using the Milan Ultrasound Criteria appears feasible with HHIUS, whereas color Doppler performance in Crohn's disease remains insufficiently validated. Hardware accessibility alone does not ensure IUS competency. Safe implementation requires structured training, including supervised practice, image quality review, and feedback, which may be supplemented by real-time telementoring and artificial intelligence. Taken together, HHIUS may be best positioned as a complementary bedside adjunct for triage, focused assessment, selected monitoring, resource-limited settings, and education, with predefined escalation to conventional IUS, magnetic resonance enterography/computed tomography, or endoscopic reassessment when appropriate. Future studies are needed to evaluate color Doppler performance, interdevice reproducibility, and safe integration of HHIUS into clinical workflows and training programs.</p>","PeriodicalId":13623,"journal":{"name":"Inflammatory Bowel Diseases","volume":" ","pages":""},"PeriodicalIF":5.5000,"publicationDate":"2026-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Inflammatory Bowel Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ibd/izag147","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Gastroenterologist-performed intestinal ultrasound (IUS) is increasingly used to monitor inflammatory bowel disease (IBD) due to its noninvasive, real-time, and cost-effective attributes, alongside high diagnostic accuracy. However, wider adoption remains limited by the cost, size, and workflow demands of cart-based or high-end ultrasound platforms. Handheld ultrasound has emerged as a miniaturized alternative that can be and applied at the bedside. Early studies of handheld intestinal ultrasound (HHIUS) in IBD have demonstrated reproducibility and diagnostic performance comparable to conventional IUS for selected applications, particularly bowel wall thickness assessment, with limitations in assessing deep pelvic lesion and complications. Whereas interdevice comparisons specific to IBD are lacking, data from general medicine suggest rapid improvements in image quality and usability of handheld devices. However, most comparative studies have not evaluated color Doppler, a core IUS parameter. In ulcerative colitis, Doppler-inclusive assessment using the Milan Ultrasound Criteria appears feasible with HHIUS, whereas color Doppler performance in Crohn's disease remains insufficiently validated. Hardware accessibility alone does not ensure IUS competency. Safe implementation requires structured training, including supervised practice, image quality review, and feedback, which may be supplemented by real-time telementoring and artificial intelligence. Taken together, HHIUS may be best positioned as a complementary bedside adjunct for triage, focused assessment, selected monitoring, resource-limited settings, and education, with predefined escalation to conventional IUS, magnetic resonance enterography/computed tomography, or endoscopic reassessment when appropriate. Future studies are needed to evaluate color Doppler performance, interdevice reproducibility, and safe integration of HHIUS into clinical workflows and training programs.

手持式肠超声在炎性肠病中的临床评价:进展如何?
胃肠病学家进行的肠道超声(IUS)越来越多地用于监测炎症性肠病(IBD),因为它具有非侵入性、实时性和成本效益,以及高诊断准确性。然而,更广泛的采用仍然受到成本、尺寸和基于小车或高端超声平台的工作流程需求的限制。手持式超声已经成为一种小型化的替代方案,可以在床边使用。早期研究表明,手持式肠道超声(HHIUS)在IBD中的重复性和诊断性能可与传统IUS媲美,特别是在评估肠壁厚度方面,但在评估深盆腔病变和并发症方面存在局限性。虽然缺乏针对IBD的设备间比较,但来自普通医学的数据表明,手持设备的图像质量和可用性得到了迅速改善。然而,大多数比较研究并未评估作为IUS核心参数的彩色多普勒。在溃疡性结肠炎中,HHIUS使用米兰超声标准进行多普勒包容性评估是可行的,而克罗恩病的彩色多普勒表现仍未得到充分验证。硬件可访问性本身并不能保证IUS的能力。安全的实施需要结构化的培训,包括监督实践、图像质量审查和反馈,这可以通过实时远程监控和人工智能来补充。综上所述,HHIUS可能最好定位为分诊、重点评估、选择性监测、资源有限的设置和教育的辅助床边辅助,并预先升级为常规IUS、磁共振肠造影/计算机断层扫描,或在适当时进行内窥镜重新评估。未来的研究需要评估彩色多普勒性能、设备间的可重复性以及HHIUS与临床工作流程和培训计划的安全整合。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Inflammatory Bowel Diseases
Inflammatory Bowel Diseases 医学-胃肠肝病学
CiteScore
9.70
自引率
6.10%
发文量
462
审稿时长
1 months
期刊介绍: Inflammatory Bowel Diseases® supports the mission of the Crohn''s & Colitis Foundation by bringing the most impactful and cutting edge clinical topics and research findings related to inflammatory bowel diseases to clinicians and researchers working in IBD and related fields. The Journal is committed to publishing on innovative topics that influence the future of clinical care, treatment, and research.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书